5-Bromo-3-(piperidin-1-yl)pyridin-2-amine, 95.0%, 100mg

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanesulfonamide, 98%, 1g

Boc-D-Trp(For)-OH, 95.0%, 5g

(1-(4-(METHYLSULFONYL)PHENYL)-1H-PYRAZOL-4-YL)METHANOL, 95.0%, 250mg

4-Bromo-2-fluoro-5-methoxyaniline, 97%, 250mg

3-Bromophthalic Anhydride>98.0%(GC)1g

(6-(Trifluoromethyl)imidazo[1,2-a]pyridin-2-yl)methanol, 98%, 250mg

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzonitrile, 95.0%, 250mg

5-(Bromomethyl)pyridine-2-carbonitrile, 95.0%, 250mg

Hexazinone>98.0%(HPLC)(T)5g

2-Methylpropan-2-amine hydrochloride, 95%, 5g

GC capillary column ROTI®Cap-5, 25 m, 0.53 mm, 1.00 µm, 1 Piece(s)

2-HYDROXY-2-METHYL-PROPIONAMIDINE HCL, 95.0%, 10g